Clinical trial

Safety & Effectiveness Study of the Hydrus Microstent for Lowering IOP in…

NCT01539239 · Ivantis, Inc., Industry · Completed

Key facts

NCT number NCT01539239
Title Safety & Effectiveness Study of the Hydrus Microstent for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery (HORIZON)
Official title The Safety and Effectiveness of the Hydrus Aqueous Implant for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery, A Prospective, Multicenter, Randomized, Controlled Clinical Trial
Lead sponsor Ivantis, Inc., Industry
Status Completed
Study type Interventional
Conditions Primary Open Angle Glaucoma
Intervention type Device, Procedure
Interventions Hydrus Aqueous Implant, Cataract surgery
Enrollment 1,143
Start date Jan 1, 2012
Primary completion Jun 1, 2017
Completion Jun 1, 2020
First posted Feb 27, 2012
Last update posted Mar 12, 2021
Countries Canada, Germany, Italy, Mexico, Philippines, Poland, Spain, United Kingdom, United States

At a glance

  • Yes Results posted
  • 1–9 Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies